Docetaxel

mitogen-activated protein kinase 3 ; Homo sapiens







11 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 32179814 Usefulness of melatonin as complementary to chemotherapeutic agents at different stages of the angiogenic process. 2020 Mar 16 2
2 27692847 Molecular complexity of taxane-induced cytotoxicity in prostate cancer cells. 2017 Jan 1
3 26821209 Long chain n-3 polyunsaturated fatty acids increase the efficacy of docetaxel in mammary cancer cells by downregulating Akt and PKCε/δ-induced ERK pathways. 2016 Apr 6
4 26909952 Docetaxel enhances apoptosis and G2/M cell cycle arrest by suppressing mitogen-activated protein kinase signaling in human renal clear cell carcinoma. 2016 Feb 5 2
5 23788635 Residual prostate cancer cells after docetaxel therapy increase the tumorigenic potential via constitutive signaling of CXCR4, ERK1/2 and c-Myc. 2013 Sep 5
6 24316750 IL-17A is produced by breast cancer TILs and promotes chemoresistance and proliferation through ERK1/2. 2013 Dec 9 2
7 21455800 Concurrent and sequential administration of sunitinib malate and docetaxel in human non-small cell lung cancer cells and xenografts. 2012 Jun 1
8 21685708 Inhibitory effects of docetaxel on platelet-derived growth factor (PDGF)-BB-induced proliferation of vascular smooth muscle cells through blocking PDGF-receptor β phosphorylation. 2011 1
9 21798065 Effects of ulinastatin and docetaxel on breast cancer invasion and expression of uPA, uPAR and ERK. 2011 Jul 29 3
10 20664934 Role of extracellular signal-regulated kinase (ERK)1/2 in multicellular resistance to docetaxel in MCF-7 cells. 2010 Sep 4
11 17317842 Docetaxel-induced apoptosis of human melanoma is mediated by activation of c-Jun NH2-terminal kinase and inhibited by the mitogen-activated protein kinase extracellular signal-regulated kinase 1/2 pathway. 2007 Feb 15 2